Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Levocetirizine 5 mg tablets versus Xyzal 5 mg tablets in healthy Thai volunteers under fasting
TCTR20230811005Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of levocetirizine in allergic rhinitis (AR) and urticaria (2 arms), sponsored by Bio-innova. Primary endpoint: Primary pharmacokinetic bioequivalence parameters. Status: unknown.
02
Drugs
levocetirizine
03
Conditions
allergic rhinitis (AR)urticaria
Beyond the preview
Go deeper on TCTR20230811005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230811005.